{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:21:13Z","timestamp":1780629673710,"version":"3.54.1"},"reference-count":45,"publisher":"Informa UK Limited","issue":"18","funder":[{"name":"Lilly"},{"name":"AbbVie, Almirall, Eli Lilly and Company, Galderma, Leo Pharma, Pierre Fabre, Novartis, Sanofi, Sun Pharma and Janssen Pharmaceuticals"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.2217\/imt-2023-0078","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T09:14:04Z","timestamp":1697620444000},"page":"1521-1529","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Infectious Adverse Events in Patients with Atopic Dermatitis Treated with Baricitinib"],"prefix":"10.1080","volume":"15","author":[{"given":"Flaminia","family":"Antonelli","sequence":"first","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"Malvaso","sequence":"additional","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Caldarola","sequence":"additional","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara De","family":"Simone","sequence":"additional","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-0387","authenticated-orcid":false,"given":"Andrea","family":"Chiricozzi","sequence":"additional","affiliation":[{"name":"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, 00168, Italy"},{"name":"UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A\u00a0Gemelli \u2013 IRCCS, Rome, 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2023911"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3511"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.08.016"},{"issue":"1","key":"e_1_3_5_6_1","first-page":"1","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis in adults","volume":"28","author":"Abduelmula A","year":"2023","unstructured":"Abduelmula A , RankinBD , MuftiAet al. Tralokinumab for moderate-to-severe atopic dermatitis in adults. Skin Ther. Lett.28(1), 1\u20136 (2023).","journal-title":"Skin Ther. Lett."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18345"},{"key":"e_1_3_5_8_1","unstructured":"AbbVie . USFDA Approves RINVOQ\u00ae (Upadacitinib) to treat adults and children 12years and older with refractory moderate to severe atopic dermatitis. https:\/\/news.abbvie.com\/news\/press-releases\/us-fda-approves-rinvoq-upadacitinib-to-treat-adults-and-children-12-years-and-older-with-refractory-moderate-to-severe-atopic-dermatitis.htm"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.009"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02281-4"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3557"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20982"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0383-4"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2018.05.004"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S356316"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2042254"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1874"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2014323"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00684-1"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.018"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1839008"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.028"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3260"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17278"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18816"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21630"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02445-w"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16948"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18898"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18193"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00602-x"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00828-5"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2161812"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.1088"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16350"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.3978"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16763"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.009"},{"key":"e_1_3_5_41_1","unstructured":"US FDA . FDA approves first systemic treatment for alopecia areata. www.fda.gov\/news-events\/press-announcements\/fda-approves-first-systemic-treatment-alopecia-areata"},{"issue":"23","key":"e_1_3_5_42_1","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.2022.9846","article-title":"Baricitinib Is first approved COVID-19 immunomodulatory treatment","volume":"327","author":"Rubin R","year":"2022","unstructured":"Rubin R . Baricitinib Is first approved COVID-19 immunomodulatory treatment. JAMA327(23), 2281 (2022).","journal-title":"JAMA"},{"key":"e_1_3_5_43_1","unstructured":"EMA . Janus kinase inhibitors (JAKi). www.ema.europa.eu\/en\/medicines\/human\/referrals\/janus-kinase-inhibitors-jaki"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"issue":"1","key":"e_1_3_5_45_1","first-page":"201","article-title":"Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases","volume":"10","author":"Salinas CA","year":"2023","unstructured":"Salinas CA , LouderA , PolinskiJB023Study Consortiumet al. Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases. Rheumatol Ther.10(1), 201\u2013223 (2023).","journal-title":"Rheumatol Ther."},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18922"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2161812"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2023-0078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:27:20Z","timestamp":1715984840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2023-0078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":45,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.2217\/imt-2023-0078"],"URL":"https:\/\/doi.org\/10.2217\/imt-2023-0078","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}